CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-30 | Castle Jeremy Chief Operating Officer | Grant or award | +12,340 | 12,340 | ||
| 2023-11-30 | Castle Jeremy Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +30,849 | 30,849 | ||
| 2023-11-21 | Hively Brad Director | Returned to the company | −25,867 | $2.19 | $57K | 671,198 |
| 2023-11-21 | Virnich Daniel Chief Executive Officer | Returned to the company | −4,322 | $2.19 | $9K | 729,603 |
| 2023-11-21 | Podnos Yale Chief Medical Officer | Returned to the company | −1,530 | $2.19 | $3K | 86,838 |
| 2023-11-17 | Hively Brad Director | Option exercise | +25,000 | $0.85 | $21K | 722,065 |
| 2023-11-17 | Hively Brad Director | Sale | −25,000 | $2.24 | $56K | 697,065 |
| 2023-11-17 | Hively Brad Director | Option exercise · Non-Qualified Stock Option (right to buy) | −25,000 | 1,745,431 | ||
| 2023-11-14 | Podnos Yale Chief Medical Officer | Returned to the company | −238 | $2.39 | $568 | 90,228 |
| 2023-11-14 | Podnos Yale Chief Medical Officer | Returned to the company | −1,860 | $2.39 | $4K | 88,368 |
| 2023-11-14 | Virnich Daniel Chief Executive Officer | Returned to the company | −4,604 | $2.39 | $11K | 733,925 |
| 2023-11-14 | Hively Brad Director | Returned to the company | −27,117 | $2.39 | $65K | 697,065 |
| 2023-11-13 | Hively Brad Director | Option exercise | +47,000 | $0.85 | $40K | 771,182 |
| 2023-11-13 | Hively Brad Director | Sale | −47,000 | $2.52 | $119K | 724,182 |
| 2023-11-13 | Hively Brad Director | Option exercise · Non-Qualified Stock Option (right to buy) | −47,000 | 1,770,431 | ||
| 2023-05-23 | Shah Mihir Chief Financial Officer | Returned to the company | −2,573 | $0.43 | $1K | 224,341 |
| 2023-05-23 | Shah Mihir Chief Financial Officer | Returned to the company | −869 | $0.43 | $372 | 223,472 |
| 2023-03-17 | Kaushal Mohit Director | Grant or award | +19,685 | 42,393 | ||
| 2023-03-17 | Podnos Yale Chief Medical Officer | Grant or award | +33,219 | 90,466 | ||
| 2023-03-17 | Podnos Yale Chief Medical Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +83,047 | 83,047 |
Page 11 of 18 · 354 trades